Ross MacDonald
Corporate Officer/Principal bei Licensing Executives Society of Australia & New Zealand
Vermögen: 247 920 $ am 31.03.2024
Profil
Ross Alexander MacDonald currently works at Uniseed Management Pty Ltd., as Investment committee Member and Licensing Executives Society of Australia & New Zealand, as Member.
Dr. MacDonald also formerly worked at Algorae Pharmaceuticals Ltd., as Chief Executive Officer in 2011, Cynata Therapeutics Ltd., as Chief Executive Officer & Managing Director in 2013, Telesso Technologies Ltd., as Non-Executive Director from 2003 to 2013, Stiefel Research Australia Pty Ltd., as Managing Director, Respiri Ltd., as Independent Non-Executive Director from 2012 to 2014, Hatchtech Pty Ltd., as Non-Executive Director in 2013, Relevare Pharmaceuticals Ltd., as Non-Executive Director, Connetics Corp., as Vice President-Business Development, FH Faulding & Co. Ltd., as Vice President-Research & Development, Stiefel Laboratories, Inc. (New York), as Vice President-Corporate Develop from 2006 to 2013, and Sinclair Pharmaceuticals Ltd., as Vice President-Business Development.
Dr. MacDonald received his doctorate degree from Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.08.2023 | 2 000 000 ( 1,11% ) | 247 920 $ | 31.03.2024 |
Aktive Positionen von Ross MacDonald
| Unternehmen | Position | Beginn |
|---|---|---|
| Licensing Executives Society of Australia & New Zealand | Corporate Officer/Principal | - |
Uniseed Management Pty Ltd.
 Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Ross MacDonald
| Unternehmen | Position | Ende |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Chief Executive Officer | 01.07.2023 |
| RESPIRI LIMITED | Director/Board Member | 05.02.2014 |
| TELESSO TECHNOLOGIES LTD. | Director/Board Member | 19.11.2013 |
| ALGORAE PHARMACEUTICALS LIMITED | Chief Executive Officer | 24.06.2011 |
Relevare Pharmaceuticals Ltd.
 Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Ausbildung von Ross MacDonald
| Monash University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| RESPIRI LIMITED | Health Technology |
| CYNATA THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Telesso Technologies Ltd.
 Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Telesso Technologies Ltd. was engaged in biotechnology research and development. The company was founded on December 15, 1995 and was headquartered in Melbourne, Australia. | Health Technology |
| FH Faulding & Co. Ltd. | Health Technology |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Finance |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Health Technology |
Stiefel Laboratories, Inc. (New York)
 Stiefel Laboratories, Inc. (New York) Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. (New York) develops, manufactures and markets products for the care and treatment of skin diseases. The company is headquartered in Oak Hill, NY. | Health Technology |
Sinclair Pharmaceuticals Ltd.
 Sinclair Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1971, Sinclair Pharmaceuticals Ltd. is a subsidiary of Huadong Medicine Co., Ltd. that manufactures and distributes pharmaceutical products. The private company is based in Chester, UK. | Health Technology |
| Licensing Executives Society of Australia & New Zealand | |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
